Food and Drug Administration Drug Safety Podcast
FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering
- Autor: Podcast
- Narrador: Podcast
- Editora: Podcast
- Duração: 0:03:00
- Mais informações
Informações:
Sinopse
FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering
